Zenith presents at BIO Investor Forum Oct 17th

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith presents at BIO Investor Forum Oct 17th

posted on Oct 08, 2018 05:39PM

Busy day on Oct 17th at BIO Investor Forum in San Francisco. All times Pacific. Resverogix on the podium at 3 PM, Zenith at 3:30 PM and our friends at BiOasis at 2 PM.

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply